The Motley Fool
15 Nov 2025, 08:06 UTC · 44w ago
Verdict
Headline takes no side. We score TPB +0.90 across four claims — strongly bullish.
+0.90strongly bullish
More positive than 95% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish
Turning Point Brands (TPB) raised its 2025 Modern Oral sales forecast to $125 million–$130 million, up from the original $60 million–$80 million guidance.
More positive than 99% of claims this week
Turning Point Brands reported a 628% year-over-year increase in Q3 sales for its Modern Oral nicotine pouch line, reaching $37 million.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Search tags
More positive than 93% of claims this week
Turning Point Brands' Q3 net income rose 70% year-over-year to $21 million, with diluted EPS increasing to $1.13 from $0.68.
More positive than 86% of claims this week
Cannell Capital LLC substantially increased its position in TPB during Q3, bringing the stake to 2.71% of its reportable assets under management.
More positive than 63% of claims this week
Which stocks this story touches
More positive than 95% of ticker scores this week
The company reported robust Q3 sales growth, a massive surge in its nicotine pouch line, and increased guidance, attracting significant institutional investment from Cannell Capital.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
−40.2%
Price is moving against the score
$60.50 vs $101.22 close before publication (Nov 14) · not market-adjusted
TPB chart →
